🇺🇸 FDA
Patent

US 11957740

Complex of botulinum neurotoxin E and its binding protein as a formulation with enhanced potency

granted A61KA61K38/4893A61K8/64

Quick answer

US patent 11957740 (Complex of botulinum neurotoxin E and its binding protein as a formulation with enhanced potency) held by Prime Bio, Inc. expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Prime Bio, Inc.
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/4893, A61K8/64, A61K8/99